跳至主要内容
临床试验/ISRCTN73824458
ISRCTN73824458已完成未知

European/Australasian Stroke Prevention in Reversible Ischaemia Trial: ESPIRIT

niversity Medical Center Utrecht (Netherlands)0 个研究点目标入组 2,739 人开始时间: 2004年9月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,739

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients presenting in the participating hospitals with a transient ischaemic attack (TIA) or non-disabling stroke of atherosclerotic origin
  • 2. Randomisation within 6 months after the TIA or minor stroke
  • 3. Modified Rankin scale of 3 or less

排除标准

  • 1. (Contra)indication to, or intolerance to, anticoagulants, dipyridamole, or aspirin
  • 2. Disease expected to cause death within weeks or months
  • 3. Source of embolism in the heart
  • 4. Moderate or severe ischemic damage to the white matter of the brain (leukoaraiosis)
  • 5. Anemia, polycythemia, thrombocytosis, or thrombocytopenia
  • 6. Planned carotid endarterectomy
  • 7. Intracranial bleeding or cerebral tumour
  • 8. TIA or stroke caused by vasculitis, migraine, or dissection
  • 9. Severe hypertension
  • 10. Liver failure
  • 11. Pregnancy
  • 12. Chronic alcohol abuse

研究者

发起方
niversity Medical Center Utrecht (Netherlands)

相似试验